Clinical Trial Update: Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Ziv-Aflibercept in advanced progressive carcinoid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor

Drugs mentioned

• Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Carcinoid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2022-11-09